EUVIMEDEUVIMED entdecken
Metaanalyse

Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation

Frank Qian, Nathan Tintle, Paul N Jensen, Rozenn N Lemaitre, Fumiaki Imamura, Tobias Rudholm Feldreich, Sarah Oppeneer Nomura, Weihua Guan, Federica Laguzzi, Eunjung Kim, Jyrki K Virtanen, Marinka Steur und 37 weitere

Journal of the American College of Cardiology · 2023

DOI: 10.1016/j.jacc.2023.05.024 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of the American College of Cardiology, 2023. Verfasst von Frank Qian und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Department of Medicine, Beth Israel Deaconess Medical…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Fatty Acids, Omega-3. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The relationship between omega-3 fatty acids and atrial fibrillation (AF) remains controversial. OBJECTIVES: This study aimed to determine the prospective associations of blood or adipose tissue levels of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) with incident AF. METHODS: We used participant-level data from a global consortium of 17 prospective cohort studies, each with baseline data on blood or adipose tissue omega-3 fatty acid levels and AF outcomes. Each participating study conducted a de novo analyses using a prespecified analytical plan with harmonized definitions for exposures, outcome, covariates, and subgroups. Associations were pooled using inverse-variance weighted meta-analysis. RESULTS: Among 54,799 participants from 17 cohorts, 7,720 incident cases of AF were ascertained after a median 13.3 years of follow-up. In multivariable analysis, EPA levels were not associated with incident AF, HR per interquintile range (ie, the difference between the 90th and 10th percentiles) was 1.00 (95% CI: 0.95-1.05). HRs for higher levels of DPA, DHA, and EPA+DHA, were 0.89 (95% CI: 0.83-0.95), 0.90 (95% CI: 0.85-0.96), and 0.93 (95% CI: 0.87-0.99), respectively. CONCLUSIONS: In vivo levels of omega-3 fatty acids including EPA, DPA, DHA, and EPA+DHA were not associated with increased risk of incident AF. Our data suggest the safety of habitual dietary intakes of omega-3 fatty acids with respect to AF risk. Coupled with the known benefits of these fatty acids in the prevention of adverse coronary events, our study suggests that current dietary guidelines recommending fish/omega-3 fatty acid consumption can be maintained.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationFatty Acids, Omega-3HumansBiomarkersDocosahexaenoic AcidsEicosapentaenoic AcidProspective StudiesRisk Factors

Stichwörter der Autor:innen

biomarkersdocosahexaenoic aciddocosapentaenoic acideicosapentaenoic acidobservational epidemiology

Substanzen

BiomarkersDocosahexaenoic AcidsEicosapentaenoic AcidFatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Mathematics and Statistics, Dordt University, Sioux Center, Iowa, USA; Fatty Acid Research Institute, Sioux Falls, South Dakota, USA.
  • Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom.
  • School of Health and Social Sciences, Dalarna University, Falun, Sweden; Center for Clinical Research Dalarna, Region Dalarna, Falun, Sweden.
  • Department of Lab Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.

Förderung

  • Medical Research Council

Zitieren

APA

Qian, F., Tintle, N., Jensen, P. N., Lemaitre, R. N., Imamura, F., Feldreich, T. R., Nomura, S. O., Guan, W., Laguzzi, F., Kim, E., Virtanen, J. K., Steur, M., Bork, C. S., Hirakawa, Y., O'Donoghue, M. L., Sala-Vila, A., Ardisson Korat, A. V., Sun, Q., Rimm, E. B., …, & Fatty Acids and Outcomes Research Consortium (FORCE) (2023). Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2023.05.024

Vancouver

Qian F, Tintle N, Jensen PN, Lemaitre RN, Imamura F, Feldreich TR, et al. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation. Journal of the American College of Cardiology. 2023. doi:10.1016/j.jacc.2023.05.024

BibTeX
@article{Qian2023,
  author = {Qian, Frank and Tintle, Nathan and Jensen, Paul N and Lemaitre, Rozenn N and Imamura, Fumiaki and Feldreich, Tobias Rudholm and Nomura, Sarah Oppeneer and Guan, Weihua and Laguzzi, Federica and Kim, Eunjung and Virtanen, Jyrki K and Steur, Marinka and Bork, Christian S and Hirakawa, Yoichiro and O'Donoghue, Michelle L and Sala-Vila, Aleix and Ardisson Korat, Andres V and Sun, Qi and Rimm, Eric B and Psaty, Bruce M and Heckbert, Susan R and Forouhi, Nita G and Wareham, Nicholas J and Marklund, Matti and Risérus, Ulf and Lind, Lars and Ärnlöv, Johan and Garg, Parveen and Tsai, Michael Y and Pankow, James and Misialek, Jeffrey R and Gigante, Bruna and Leander, Karin and Pester, Julie A and Albert, Christine M and Kavousi, Maryam and Ikram, Arfan and Voortman, Trudy and Schmidt, Erik B and Ninomiya, Toshiharu and Morrow, David A and Bayés-Genís, Antoni and O'Keefe, James H and Ong, Kwok Leung and Wu, Jason H Y and Mozaffarian, Dariush and Harris, William S and Siscovick, David S and Fatty Acids and Outcomes Research Consortium (FORCE), Fatty Acids and Outcomes Research Consortium (FORCE)},
  title = {Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation},
  journal = {Journal of the American College of Cardiology},
  year = {2023},
  doi = {10.1016/j.jacc.2023.05.024}
}
Kostenlos starten →